People with Alzheimer’s disease are helping with a ground-breaking government-funded trial but with new sites recently opened in the South West more people are being asked to take part in the study led by academics from the Universities of Bristol, Cambridge, Queen’s University Belfast and University College London, and hosted by North Bristol NHS Trust.
The GW4 Alliance is set to launch a new PhD programme for health professionals after receiving a £7m grant from the Wellcome Trust.
Children and young people with severe obesity will receive intensive support with a pilot of 15 new specialist NHS services based on a clinic in Bristol.
A new treatment for stimulating the growth of new blood vessels in the heart will be investigated by researchers at the University of Bristol thanks to funding of over £100,000 from national charity Heart Research UK.
New research has found if healthcare inequalities in the most deprived areas of England were reduced, this could help save the NHS around £28.8 million each year in hip fracture treatment costs.
The University of Bristol and spin-out company Imophoron have announced they are ready to test COVID-19 vaccine candidates in a pre-clinical programme.
While child deaths in England fell temporarily during the COVID-19 pandemic, they have now risen to new heights, a new study from researchers at the University of Bristol and based on unique National Child Mortality Database (NCMD) data has found.
New research by academics at the University of Bristol has found evidence that prolonged treatment of synthetic corticosteroid drugs increases adrenal gland inflammation in response to bacterial infection, an effect that in the long-term can damage adrenal function.
Parents attending an adult weight management programme, who were worried about their child’s weight, would accept support and signposting to services for their child if it was offered, new research led by the University of Bristol has found. The study is published today [21 January] in BMJ Paediatrics Open.
Bristol’s heart scientists are involved in one of two new Medical Research Council Centres of Research Excellence (MRC CoRE) that aims to develop new advanced therapeutics for currently untreatable diseases. Both Centres will receive up to £50 million each over 14 years.
